ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo takes on advanced lung cancer
Disease control Recruiting nowThis study tests a new combination of two drugs, AMT116 and ivosimab, in people with advanced non-small cell lung cancer that cannot be removed by surgery. The goal is to find the safest dose and see if the combination shrinks tumors. About 118 adults aged 18 to 75 will take part…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug cocktail targets tough lung cancer
Disease control Recruiting nowThis phase 2 trial tests a new drug called AK146D1, given together with other cancer drugs, in 348 people with advanced non-small cell lung cancer that cannot be surgically removed. The study aims to see if the combination is safe and can shrink tumors. Participants will receive …
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Blood test could speed up lung cancer treatment decisions
Knowledge-focused Recruiting nowThis study looks at whether a blood test called liquid biopsy can quickly find genetic changes in people with advanced lung cancer. About 70 adults will give a blood sample, and researchers will compare the results to standard tissue biopsies. The goal is to see if this approach …
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Sponsor: Regina Elena Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to crack the code on cancer drug resistance
Knowledge-focused Recruiting nowThis study looks at how well certain markers in tumors can predict whether a type of targeted cancer treatment called antibody-drug conjugates (ADCs) will work. About 400 adults with advanced breast, stomach, bladder, or lung cancer will provide tumor samples before and after tre…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC